• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.44% Nasdaq Up0.66%

    Tetraphase Pharmaceuticals, Inc. (TTPH)

    -NasdaqGS
    37.14 Up 0.74(2.03%) 12:31PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 10,486   7,600   185  
    Cost of Revenue -   -   -  
    Gross Profit 10,486   7,600   185  
    Operating Expenses
    Research Development31,508  17,294  17,737  
    Selling General and Administrative7,168  4,309  3,874  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (28,190) (14,003) (21,426)
    Income from Continuing Operations
    Total Other Income/Expenses Net273  (63)23  
    Earnings Before Interest And Taxes(27,917)(14,066)(21,403)
    Interest Expense1,719  1,021  161  
    Income Before Tax(29,636)(15,087)(21,564)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(29,636)(15,087)(21,564)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (29,636) (15,087) (21,564)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (29,636) (15,087) (21,564)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.